Back
Nuvectis Pharma, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
NVCT
Nuvectis Pharma, Inc.
Last Price:
$7.56
Seasonality Move:
11.74%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVCT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Nuvectis Pharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.7 | Sell |
| 20-day SMA: | 8.36 | Sell |
| 50-day SMA: | 8.56 | Sell |
| 200-day SMA: | 7.33 | Buy |
| 8-day EMA: | 7.75 | Sell |
| 20-day EMA: | 8.13 | Sell |
| 50-day EMA: | 8.29 | Sell |
| 200-day EMA: | 7.73 | Sell |
Nuvectis Pharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 34.68 | Sell |
| Chaikin Money Flow: | 16153 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.83 - 9.11) | Sell |
| Bollinger Bands (100): | (6.86 - 8.92) | Sell |
Nuvectis Pharma, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nuvectis Pharma, Inc. Stock
Is Nuvectis Pharma, Inc. Stock a Buy?
-
Nuvectis Pharma, Inc. share price is 7.56 while NVCT 8-day simple moving average is 7.70, which is a Sell signal.
-
The stock price of NVCT is 7.56 while Nuvectis Pharma, Inc. 20-day SMA is 8.36, which makes it a Sell.
-
Nuvectis Pharma, Inc. 50-day simple moving average is 8.56 while NVCT share price is 7.56, making it a Sell technically.
-
NVCT stock price is 7.56 and Nuvectis Pharma, Inc. 200-day simple moving average is 7.33, creating a Buy signal.
NVCT Technical Analysis vs Fundamental Analysis
Sell
47
Nuvectis Pharma, Inc. (NVCT)
is a Sell
Is Nuvectis Pharma, Inc. a Buy or a Sell?
-
Nuvectis Pharma, Inc. stock is rated a SellThe current Nuvectis Pharma, Inc. [NVCT] share price is $7.56. The Score for NVCT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Nuvectis Pharma, Inc. Stock Info
Market Cap:
199.2M
Price in USD:
7.56
Share Volume:
18.3K
Nuvectis Pharma, Inc. 52-Week Range
52-Week High:
11.52
52-Week Low:
5.55
Sell
47
Nuvectis Pharma, Inc. (NVCT)
is a Sell
Nuvectis Pharma, Inc. Share Price Forecast
-
What is the Nuvectis Pharma, Inc. stock price today?The Nuvectis Pharma, Inc. stock price is 7.56 USD today.
-
Will NVCT stock go up or go down?Nuvectis Pharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Nuvectis Pharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nuvectis Pharma, Inc. is overvalued.
Is Nuvectis Pharma, Inc. Stock a Buy?
-
Nuvectis Pharma, Inc. share price is 7.56 while NVCT 8-day exponential moving average is 7.75, which is a Sell signal.
-
The stock price of NVCT is 7.56 while Nuvectis Pharma, Inc. 20-day EMA is 8.13, which makes it a Sell.
-
Nuvectis Pharma, Inc. 50-day exponential moving average is 8.29 while NVCT share price is 7.56, making it a Sell technically.
-
NVCT stock price is 7.56 and Nuvectis Pharma, Inc. 200-day simple moving average is 7.73, creating a Sell signal.
Technical Analysis of Nuvectis Pharma, Inc.
Should I short Nuvectis Pharma, Inc. stock?
-
NVCT Moving Average Covergence Divergence (MACD) indicator is -0.32, suggesting Nuvectis Pharma, Inc. is a Sell
-
Nuvectis Pharma, Inc. Relative Strength Index (RSI) is 34.68, which suggest Nuvectis Pharma, Inc. is oversold
-
The Bollinger Bands (25) for Nuvectis Pharma, Inc. is (7.83 - 9.11), which suggest Nuvectis Pharma, Inc. is a Sell
-
The Bollinger Bands (100) for Nuvectis Pharma, Inc. is (6.86 - 8.92), which suggest Nuvectis Pharma, Inc. is a Sell
* Nuvectis Pharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.